Gene alterations of glycosyltransferase during the course of malignant tranformation in uterine endometrium

子宫内膜恶变过程中糖基转移酶基因的改变

基本信息

  • 批准号:
    06671685
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1996
  • 项目状态:
    已结题

项目摘要

Monoclonal antibody MSN-1 was established against an endometrial cancer cell line and proven to recognize at least Lewis b carbohydrate antigen. Immunohistochemical staining with this antibody resulted in a positive reaction in more than 85% of the endometrial adenocarcinoma cases examined but in few cases with normal endometria, indicating that MSN-1-reactive antigen is able to be a good histochemical marker for endometrial cancers. Expression of the Lewis histo-blood group antigen is determined by the Lewis type alpha (1,3/1,4) fucosyltransferase enconded by the FucT-III gene (Le gene). Since Lewis-negative individuals are known to be homozygous for an allele with missense mutations of this gene (le/le) which cause inactivation of the enzyme activity, we investigated whether or not phenotypic expression of the MSN-1-reactive antigen in endometrial adenocarcinoma specimens was affected by the genotypes of the FucT-III gene in patients with adenocarcinoma. To determine the genotypesof the FucT-III gene, i.e., to detect the mutations, we employed the polymerase chain reaction (PCR) -restriction fragment length polymorphism method by using genomic DNAs extracted from the patients'peripheral blood leucocytes as PCR templates. Out of 59 cases of endometrial adenocarcinoma, four cases with the Lewis-negative genotype (le/le) were identified and examined by the ABC immunohistochemical technique for the presence of the MSN-1-reactive antigen on their cancer cells. The conventional hemagglutination reaction also revealed all four of these cases to have the Lewis-negative blood type. However, their cancer tissues reacted positively with MSN-1. These results suggest that MSN-1 recognizes a fucosylated carbohydrate that is constructed by fucosyltransferases other than FucT-III.
针对子宫内膜癌细胞系建立了单克隆抗体MSN-1,并证明其至少识别刘易斯B糖抗原。免疫组化染色与此抗体导致阳性反应,在85%以上的子宫内膜腺癌的情况下检查,但在少数情况下,正常子宫内膜,表明MSN-1反应性抗原是一个很好的组织化学标记子宫内膜癌。刘易斯组织血型抗原的表达由FucT-III基因(Le基因)编码的刘易斯型α(1,3/1,4)岩藻糖基转移酶决定。由于路易斯阴性个体是纯合子的等位基因与错义突变的这个基因(le/le),导致失活的酶活性,我们调查是否表型表达的MSN-1反应性抗原在子宫内膜腺癌标本是受影响的基因型的FucT-III基因在腺癌患者。为了确定FucT-III基因的基因型,即,为了检测突变,我们采用聚合酶链反应(PCR)-限制性片段长度多态性方法,以从患者外周血白细胞中提取的基因组DNA作为PCR模板。在59例子宫内膜腺癌中,4例Lewis阴性基因型(le/le)被确定,并通过ABC免疫组化技术检查其癌细胞上MSN-1反应抗原的存在。常规的血凝反应也显示所有这四个病例都有路易斯阴性血型。然而,他们的癌组织与MSN-1呈阳性反应。这些结果表明,MSN-1识别由岩藻糖基转移酶而不是FucT-III构建的岩藻糖基化碳水化合物。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fukuda,M.N.: "Trophinin and tastin;a novel cell adhesion molecule complex with potential involvement in embryo implantation" Genes and Development. 9. 1199-1210 (1995)
Fukuda,M.N.:“肌营养蛋白和味素;一种新型细胞粘附分子复合物,可能参与胚胎植入”基因与发育。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.N.Fukuda, T.Sato, J.Nakayama, G.Klier, M.Mikami, D.Aoki, and S.Nozawa: "Trophinin and tastin ; a novel cell adhesion molecule complex with potential involvement in embryo implantation" Genes and Development.9. 1199-1210 (1995)
M.N.Fukuda、T.Sato、J.Nakayama、G.Klier、M.Mikami、D.Aoki 和 S.Nozawa:“Trophinin 和 tastin;一种新型细胞粘附分子复合物,可能参与胚胎植入”基因与发育。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
青木大輔: "細胞診の見方と考え方〔27〕培養細胞を免疫源として作製したモノクローナル抗体による免疫組織細胞化学的解析" 臨床と病理. 12. 1235-1241 (1994)
Daisuke Aoki:“细胞诊断的观点和概念 [27] 使用从培养细胞制备的单克隆抗体作为免疫原进行免疫组织细胞化学分析”《临床和病理学》12. 1235-1241 (1994)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
青木大輔: "子宮体癌の手術療法の選択" 癌と化学療法. 22. 1163-1168 (1995)
Daisuke Aoki:“子宫癌的手术治疗选择”《癌症与化疗》22. 1163-1168 (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Aoki, D.: "Phenotypic alteration of carbohydrate antigens in gynecological malignancy" Acta Histochem. Cytochem.28 (2). 197-201 (1995)
Aoki, D.:“妇科恶性肿瘤中碳水化合物抗原的表型改变”《组织化学学报》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AOKI Daisuke其他文献

AOKI Daisuke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AOKI Daisuke', 18)}}的其他基金

Exploration of endometrial cancer-associated microRNAs by using a functional screening method and its application to medication
子宫内膜癌相关microRNA的功能筛选方法探索及其在药物治疗中的应用
  • 批准号:
    22390313
  • 财政年份:
    2010
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
DVELOPMENT OF HUMAN MONOCLONAL ANTIBODIES WHICH SHOW INHIBITORY EFFECTS TUMOR PROGRESSION.
开发具有抑制肿瘤进展作用的人类单克隆抗体。
  • 批准号:
    19390430
  • 财政年份:
    2007
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of complete human monoclonal antibodies and immune complexes for use in the treatment of cancers
开发用于治疗癌症的完整人单克隆抗体和免疫复合物
  • 批准号:
    16390478
  • 财政年份:
    2004
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The analysis on functions of aberrant carbohydrates in endometrial cancer cells and the mechanism of their expression
子宫内膜癌细胞中异常碳水化合物的功能及其表达机制分析
  • 批准号:
    10671570
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The localization of beta 1,4-galactosyltransferase and its significance for malignancy
β1,4-半乳糖基转移酶的定位及其对恶性肿瘤的意义
  • 批准号:
    04671018
  • 财政年份:
    1992
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Significance of MUC1 with sialyl-Tn carbohydrate antigen in the management of breast cancer
MUC1 与唾液酸-Tn 碳水化合物抗原在乳腺癌治疗中的意义
  • 批准号:
    23K15459
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of the mechanism of osteolytic bone destruction in bone metastasis via tumor-associated carbohydrate antigen
通过肿瘤相关糖抗原研究骨转移中溶骨性骨破坏的机制
  • 批准号:
    15K10427
  • 财政年份:
    2015
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural and functional analyses of reproduction-specific carbohydrate antigen recognized by an auto-antibody, Ts4
自身抗体 Ts4 识别的生殖特异性碳水化合物抗原的结构和功能分析
  • 批准号:
    25462575
  • 财政年份:
    2013
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
C3 Tumor Associated Carbohydrate Antigen Bioconjugates
C3 肿瘤相关碳水化合物抗原生物缀合物
  • 批准号:
    8424948
  • 财政年份:
    2012
  • 资助金额:
    $ 1.41万
  • 项目类别:
C3 Tumor Associated Carbohydrate Antigen Bioconjugates
C3 肿瘤相关碳水化合物抗原生物缀合物
  • 批准号:
    8301502
  • 财政年份:
    2012
  • 资助金额:
    $ 1.41万
  • 项目类别:
Application of novel tumor associated carbohydrate antigen as tumor marker
新型肿瘤相关糖抗原作为肿瘤标志物的应用
  • 批准号:
    23501303
  • 财政年份:
    2011
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of carbohydrate antigen clusters to enhance immunogenicity
开发碳水化合物抗原簇以增强免疫原性
  • 批准号:
    352849-2007
  • 财政年份:
    2007
  • 资助金额:
    $ 1.41万
  • 项目类别:
    University Undergraduate Student Research Awards
Study to find lectins, ligands for Sd^a carbohydrate antigen,which is normally expressed in gastrointestinal tract
研究发现凝集素,Sd^a 碳水化合物抗原的配体,通常在胃肠道中表达
  • 批准号:
    19790504
  • 财政年份:
    2007
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Elucidation of the mechanism on carbohydrate antigen recognition by B cells through CD1d mediated signaling and establishment of a method to regulate B cells responding to the carbohydrate antigens in ABO-incompatible transplantation and xe
阐明 B 细胞通过 CD1d 介导的信号识别碳水化合物抗原的机制,并建立在 ABO 不相容移植和 xe 中调节 B 细胞对碳水化合物抗原反应的方法
  • 批准号:
    18390349
  • 财政年份:
    2006
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinicopathological and functional analysis of carbohydrate antigen expression : Focusing on DU-PAN-2 (precursor of CA19-9)
碳水化合物抗原表达的临床病理学和功能分析:关注DU-PAN-2(CA19-9的前体)
  • 批准号:
    14570166
  • 财政年份:
    2002
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了